There have only been four flu pandemics since the start of the 20th century, yet concerns are widening about the potential for a new outbreak.
Cathrin Petty, co-head of EMEA healthcare at JP Morgan, says the U.K. has the capacity to be a successful market for life sciences, and the year ahead for healthcare IPOs looks strong.
George Freeman MP, minister of life sciences in the U.K., says there's been a "resurgence" for life sciences and healthcare investment.
How much would it cost world governments to insulate their economies from global pandemics. Would you believe nearly $344 billion?
A flu shot that lasts 10 years could be a reality soon, a top hospital executive told CNBC, along with "real steps" toward a cancer vaccine.
Two young engineers invented a product that uses LED lights to fight bacteria and decrease risk of infections in hospitals and public spaces.
Health care has been on a tear in 2014, and there is still room for upside. Wall Street analysts are focusing on the following four trends.
Dr. Louis Sullivan, former HHS Secretary, discusses President Obama's decision to send 3,000 U.S. troops to West Africa to help in their fight with Ebola.
Ebola outbreaks may become more frequent because of climate change, scientists warn, as the deadly disease ravages West Africa.
Shares of Malaysia's latex glove makers have had a tough year so far, but some analysts expect panic over Africa's Ebola outbreak may spur gains.
Lawrence Livermore is reaching out to private industry amid a race for talent and ideas to solve pressing issues including national security.
CRE, one of the worst of the superbugs, is spreading in some hospitals, and there's worry that cases are under-reported.
As AstraZeneca's shares slid following its rejection of Pfizer's new bid, the company's chairman said he was "reasonably confident" it was the right decision.
Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.
As healthcare reform begins to take shape, venture capitalists see emerging opportunities in digital health start-ups.
P&G is bringing the dentist into your bathroom a smartphone-connected toothbrush, a device that gives personalized advice to help people improve their brushing.
The White House is coming under pressure from some of its closest allies to name a CEO to run its health insurance marketplace.
Activist investor Carl Icahn reported a 12.63 stake in medical device maker Hologic, prompting the company to seek protection from a hostile takeover
An entrepreneur has attracted investments from four billionaires: Sam Zell, Herb Simon, David Bonderman and "one family you've never heard of."
Johnson & Johnson and its subsidiaries were accused of promoting powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.